期刊文献+

降钙素原对儿童急性肾盂肾炎的诊断价值 被引量:12

Role of procalcitonin in the diagnosis of acute pyelonephritis in children
原文传递
导出
摘要 目的探讨降钙素原(PCT)对儿童急性肾盂肾炎(APN)的诊断价值。方法回顾性分析2011年9月至2012年2月诊断为初发的尿路感染(UTI)且年龄<3岁患儿的病例资料,以核素肾静态扫描(99mTc-DMSA)结果作为诊断APN的金标准,比较上尿路感染(APN)及下尿路感染(非APN)患儿血清PCT、CRP的水平,并绘制二者诊断APN的受试者工作特征曲线(ROC曲线),判断其诊断性能。结果共65例UTI患儿纳入研究,其中APN39例,下尿路感染者26例,前者的血清PCT、CRP水平显著高于后者(分别3.08 ng/mL vs 0.37 ng/mL;6.25 mg/L vs3.01 mg/L;均P<0.01)。血清PCT诊断APN的敏感性为84.6%,特异性为88.5%,曲线下面积为0.873(95%可信区间为0.781~0.965),最佳阈值为1.03 ng/mL;血清CRP诊断APN的敏感性为71.8%,特异性为69.2%,曲线下面积为0.735(95%可信区间为0.612~0.858),最佳阈值为3.91 mg/L。结论 PCT对儿童APN的诊断具有较高的敏感性及特异性,有助于临床对APN的早期识别。 Objective To study the role of procalcitonin (PCT) in the diagnosis of acute pyelonephritis ( APN ) in children. Methods Retrospective analysis was performed on the clinical records of children aged under 3 years who were diagnosed with primary urinary tract infection (UTI) from September 2011 to February 2012. These children were divided into those with upper UTI (UUTI) (APN) and those with lower UTI (LUTI) (non-APN) based on 99mTcdimercaptosuceinic acid (DMSA) renal scan results as a gold standard. The UUTI and LUTI groups were compared in terms of serum levels of PCT and C-reactive protein (CRP). Receiver operating characteristic (ROC) curves were drawn to evaluate the diagnostic values of serum PCT and CRP. Results Sixty-five children with UTI, including 39 cases of APN and 26 cases of LUTI, were included in this study. The APN cases had significantly higher serum levels of PCT (3.08 ng/mL vs 0.37 ng/mL; P 〈0.01 ) and CRP (6.25 mg/L vs 3.01 rag/L; P 〈0.01 ) than the LUTI cases. The sensitivity and specificity of serum PCT level for APN were 84.6% and 88.5% , respectively, with an area under the ROC curve (AUC) of 0. 873 (95 % CI = 0.781-0. 965 ) and an optimal threshold point of 1.03 ng/mL. The sensitivity and specificity of serum CRP level for APN were 71.8% and 69.2% , respectively, with an AUC of 0. 735 (95% CI =0. 612-0. 858) and an optimal threshold point of 3.91 mg/L. Conclusions As a resuh of its high sensitivity and specificity for the disease, serum PCT can be used as a marker in the early diagnosis of APN in children.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2013年第2期85-87,共3页 Chinese Journal of Contemporary Pediatrics
关键词 降钙素原 急性肾盂肾炎 受试者工作特征曲线 尿路感染 儿童 Procalcitonin Acute pyelonephritis Receiver operating curve Urinary tract infection Child
  • 相关文献

参考文献10

  • 1Montini G,Tullus K,Hewitt I. Febrile urinary tract infections in children[J].New England Journal of Medicine,2011,(03):239-250.
  • 2刘延霞,杨青,林瑞霞.小儿尿路感染与膀胱输尿管反流[J].中国当代儿科杂志,2008,10(1):83-84. 被引量:7
  • 3Chen SM,Chang HM,Hung TW,Chao YH,Tsai JD,Lue KH. Diagnostic performance of procalcitonin for hospitalised children with acute pyelonephritis presenting to the paediatric emergency department[J].Emergency Medicine Journal,2012.
  • 4屈文烈,白旭明.尿路感染患者的血清降钙素原水平研究[J].临床和实验医学杂志,2008,7(12):11-12. 被引量:2
  • 5Nikfar R,Khotaee G,Ataee N,Shams S. Usefulness of procalcitonin rapid test for the diagnosis of acute pyelonephritis in children in the emergency department[J].Pediatrics International,2010,(02):196-198.
  • 6Slekovec C,Leroy J,Vernaz-Hegi N,Faller JP Sekri D Hoen B. Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns[J].Int J Clin Pharm,2012,(02):325-329.
  • 7Routh JC,Grant FD,Kokorowski PJ,Nelson CP Fahey FH Treves ST. Economic and radiation costs of initial imaging approaches after a child's first febrile urinary tract infection[J].Clinical Pediatrics(Phila),2012,(01):23-30.
  • 8Nazarko L. Urinary tract infection:diagnosis,treatment and prevention[J].British Journal of Nursing,2009,(19):1170-1174.
  • 9Gilsdorf JR. C reactive protein and procalcitonin are helpful in diagnosis of serious bacterial infections in children[J].Journal of Pediatrics,2012,(01):173-174.
  • 10Kotoula A,Gardikis S,Tsalkidis A,Mantadakis E Zissimopoulos A Kambouri K. Procalcitonin for the early prediction of renal parenchymal involvement in children with UTI:preliminary results[J].International Urology and Nephrology,2009,(02):393-399.doi:10.1007/s11255-008-9472-2.

二级参考文献13

  • 1郑立华,鲁辛辛.降钙素原的临床研究进展[J].中国实验诊断学,2007,11(1):137-139. 被引量:30
  • 2第二届肾脏病学术会议组.尿路感染诊断、治疗标准.中华肾脏病杂志,1985,1(4):13-14.
  • 3Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Mobius TE. International system of radiographic grading of vesicoureteric reflux[J]. Pediatr Radiol, 1985, 15(2) :105-109.
  • 4Cleper R, Krause I, Eisenstein B, Davidovits M. Prevalence of vesicoureteral reflux in neonatal urinary tract Infection [ J ]. Clin Pediatr, 2004, 43(7) : 619-625.
  • 5Blumenthal I. Vesicoureteric reflux and urinary tract infection in childrenl J]. Postgrad Med J, 2006, 82 (963) :31-35.
  • 6Olbing H, Smellie JM, Jodal U, Lax H. New renal scars in children with severe VUR: a 10-year study of randomized treatment [J]. Pediatr Nephrol, 2003, 18(11) :1128-1131.
  • 7Thompson M, Simon SD, Sharma V, Alon US. Timing of follow-up voiding cystourethrogram inchildren with primary vesicoureteral reflux: development and application of a clinical algorithm[J]. Pediatrics, 2005, 115(2) :426-434.
  • 8Greenfield SP, Wan J. The relationship between dysfunctional voiding and congenital vesicoureteral reflux [ J ]. Curr Opin Urol, 2000, 10(6) :607-610.
  • 9Hemdon CD, DeCambre M, McKenna PH. Changing concepts concerning the management of vesicoureteral reflux [J]. J Urol, 2001, 166(4) :1439-1443.
  • 10Kibar Y, Ors O, Demir E, Kalman S, Sakallioglu O, Dayanc M. Results of biofeedback treatment on reflux resolution rates in children with dysfunctional voiding and vesicoureteral reflux[J]. Urology, 2007, 70(30):563-567.

共引文献7

同被引文献80

  • 1徐裕海,李桂新,刘谦慧.感染性休克体液复苏治疗后C反应蛋白和降钙素原动态变化的研究[J].大连医科大学学报,2009,31(1):95-97. 被引量:29
  • 2张烈民,谭志华.CRP检测在妊娠合并急性泌尿系感染中作用探讨[J].中国优生与遗传杂志,2007,15(3):53-54. 被引量:5
  • 3Powell B,Smith I, The diagnostic role of procalcitonin inquinine-induced disseminated intravascular coagulation[J]. Anaesth Intensive Care,2013,41 (1) : 131-132.
  • 4Corona A,Colombo R,Raimondi F. Procalcitonin serumlevels:only a useful variable or a must to start antibiotictherapy in the critically ill[J]. Crit Care Med, 2013 , 41(2):18-19.
  • 5Schuetz P,Briel M,Mueller B. Clinical outcomes associat-ed with procalcitonin algorithms to guide antibiotic thera-py in respiratory tract infections [J], JAMA, 2013 , 309(7):717-718.
  • 6Jagminas L. Meta-analysis : procalcitonin-guided antibiotictherapy reduces treatment failure in acute respiratory in-fection[J]. Ann Intern Med,2013,158(4) :2-5.
  • 7Anriane D,Maxime V,Faller JP,et al. Procalcitonin levelsto guide antibiotic therapy in adults with non-microbio-logically proven apparent severe sepsis . a randomised con-trolled trial[J]. BMJ Open,2013 ,3(2) : 127-130.
  • 8Park JH,Choi SP,Wee JH. Is it cost-effective to use pro-calcitonin to predict outcome in community-acquiredpneumonia in the ED response to the authors [J]. Am JEmerg Med,2013 ,31 .2) :428-429.
  • 9Slavakis A, Papadimas J. Procalcitonin: does it play a role in Malere production [ J ]. Fertil Steril, 2000, 74 ( 6 ) : 1227 - 1228.
  • 10Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus / systemic antineutrophil cytoplasm antibody associated vasculitis) and in- vasive bacterial infection [J ] . Arthritis Rheum, 1997, 40: 1250 - 1256.

引证文献12

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部